Legislating for the new predictive genetics.
Many new genetic markers have become available for use in the diagnosis, prognosis or risk prediction of common multifactorial disease such as venous thrombo-embolism, coronary artery disease, dementias and some cancers. Regulation or legislation of their application in the fields of the family, employment, life assurance, confidentiality and property law is required. This is made difficult because of the rapid pace of genetic discoveries and their derived technologies, the diversity of opinions on the legitimate application of these new techniques, and the pluralistic and evolving social norms of society regarding the use of the new genetic methods. This paper examines some of the problems that can arise when regulation is attempted in each of the above fields. A variety of solutions such as referenda, moratoria, ethical codes of professional bodies or the drafting of scientifically accurate and appropriate legislation depending on particular circumstances are discussed as a means of achieving a flexible and responsive approach to the challenges posed by the use of the new genetic markers.
Galton
D J
DJ
Department of Human Metabolism and Genetics, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, England.
O'Donovan
K
K
D003219:Confidentiality; D030561:Databases, Nucleic Acid; D004651:Employment; D005053:Eugenics; D005190:Family; D005819:Genetic Markers; D030661:Genetic Privacy; D005820:Genetic Testing / Q000331:legislation & jurisprudence* / Q000379:methods*; D033161:Government Regulation; D017408:Guidelines as Topic; D006806:Human Rights; D006801:Humans; D007341:Insurance; D038622:Internationality; D010067:Ownership; D019836:Preimplantation Diagnosis; D011287:Prejudice; D012955:Societies, Medical; D014019:Tissue Donors; D006113:United Kingdom
D005819:Genetic Markers